The National Security Commission on Emerging Biotechnology (NSCEB) announced on April 8, 2025, the availability of its final report and action plan, “urging Congressional action to bring the full ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

STAT's Adam Feuerstein puts all his “Biotech Doom Loop” panic-mongering aside, as he embraces luminescent moonbeams and downy ...

Press Release Grove Biopharma, a private biotechnology company pioneering its Bionic Biologics™ platform to develop therapies targeting previously intractable intracellular disease targets, today ...

Celebrities like Tom Brady and Tiger Woods support the project. The Dallas-based biotechnology firm, founded by Ben Lamm, has emerged as a trailblazer in de-extinction science. But Lamm is clear ...

With over 15 years’ experience of commercial leadership in the chemical and pharma/biotech service sectors, Nathalie brings a strong track record of driving revenue growth and forging strategic ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t want to lose to China, warns a national security commission made up ...

However, the prospect of future industry-specific tariffs could intensify selling pressure on biotech stocks. Despite the uncertainty, top hedge fund managers have invested millions of dollars in ...

After a tough period of layoffs and hiring freezes, many were hoping 2025 would bring some relief to the biotech job market. But so far, that rebound hasn’t quite arrived. From cautious employers to ...

The value of Lithuania’s biotech industry, for instance, increased ten-fold between 2010 and 2020, and the country now ranks third in the world for investment in biotech R&D according to the OECD. The ...